Not independent
Tenure on this board
42.5 yrs
Meeting calendar
PAHC · Annual meeting · Tuesday, November 4, 2025
Phibro Animal Health Corp
3 nominees · 4 ballot items.
Election of Class III Directors; advisory Say-on-Pay for named executive officers; advisory Say-on-Frequency for future Say-on-Pay votes; ratification of PwC as independent auditor for the fiscal year ending June 30, 2026.
Market cap
$1.3B
1Y TSR
+30.0%
Board grade
A
Record date
Sep 12, 2025
Filing
DEF 14A
Meeting concluded · Nov 4, 2025
Follow how the vote landed and what changed on Phibro Animal Health Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot4
- 1
Election of Class III Directors
ManagementBoard: FORElection of three Class III directors to serve until the 2028 annual meeting and until their successors are duly elected and qualified.
- 2
Advisory Vote to Approve Named Executive Officer Compensation
ManagementBoard: FORAdvisory (non-binding) vote to approve the compensation of the named executive officers as disclosed in this proxy statement (say-on-pay).
- 3
Advisory Vote on the Frequency of Future Stockholder Votes on Executive Compensation
ManagementBoard: FORAn advisory vote to indicate whether stockholders prefer every 1 year, every 2 years, or every 3 years for future Say-on-Pay votes.
- 4
Ratification of the Selection of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm
ManagementBoard: FORRatification of PwC as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026.
Director elections
Nominees on the ballot3
Independent
Tenure on this board
3.4 yrs
Independent
Tenure on this board
18.2 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.6% | 2,265,823 | $125M |
| 2 | FMR LLC | 3.5% | 1,439,999 | $80M |
| 3 | STATE STREET CORP | 2.3% | 950,033 | $53M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 2.2% | 891,283 | $49M |
| 5 | BlackRock, Inc. | 1.5% | 625,344 | $35M |
| 6 | ACADIAN ASSET MANAGEMENT LLC | 1.5% | 617,072 | $34M |
| 7 | FMR LLC | 1.5% | 603,968 | $33M |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 1.4% | 576,735 | $32M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.3% | 532,912 | $29M |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.2% | 490,342 | $27M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Phibro Animal Health Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Avanos Medical IncAVNS
Special meeting·Jul 22, 2026·$1.2B
Esperion Therapeutics IncESPR
Special meeting·Jul 8, 2026·$814M
Aura Biosciences IncAURA
Special meeting·Aug 5, 2026·$734M
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.9B
Achieve Life Sciences IncACHV
Annual meeting·Jul 2, 2026·$670M
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$2.0B
Reference
Frequently asked questions
- When is the Phibro Animal Health Corp 2025 annual meeting?
- Phibro Animal Health Corp (PAHC) holds its 2025 annual shareholder meeting on Tuesday, November 4, 2025.
- What is the record date for the Phibro Animal Health Corp 2025 meeting?
- The record date for the Phibro Animal Health Corp 2025 meeting is Friday, September 12, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Phibro Animal Health Corp's 2025 meeting?
- The board is presenting 3 director nominees at the Phibro Animal Health Corp 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Phibro Animal Health Corp 2025 meeting?
- Shareholders will vote on 4 proposals at the Phibro Animal Health Corp 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.